Induction protocols: yesterday, today, and tomorrow
- 1 February 1999
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 31 (1-2) , 1100-1101
- https://doi.org/10.1016/s0041-1345(98)01919-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- INFLUENCE OF THE DURATION OF IL-2 RECEPTOR (IL-2R) BLOCKADE ON THE INCIDENCE OF ACUTE REJECTION EPISODES IN RENAL TRANSPLANTATIONTransplantation, 1998
- A PROSPECTIVE RANDOMIZED TRIAL OF NEORAL AND CELLCEPT WITH AND WITHOUT OKT3 INDUCTIONTransplantation, 1998
- CELL ADHESION MOLECULES IN CLINICAL RENAL TRANSPLANTATION1Transplantation, 1998
- Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal TransplantationNew England Journal of Medicine, 1998
- Effect of anti-lymphocyte induction therapy on renal allograft survivalJournal of the American Society of Nephrology, 1997
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsThe Lancet, 1997
- ANTILYMPHOCYTE INDUCTION THERAPY IN CADAVER RENAL TRANSPLANTATIONTransplantation, 1997
- OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: Association with improvement in long-term survivalKidney International, 1996
- EFFICACY OF REJECTION PROPHYLAXIS WITH OKT3 IN RENAL TRANSPLANTATIONTransplantation, 1995
- A RANDOMIZED CLINICAL TRIAL OF INDUCTION THERAPY WITH OKT3 IN KIDNEY TRANSPLANTATIONTransplantation, 1993